Schedule 13D ownership disclosure

AKCEA THERAPEUTICS, INC.

Security class unavailable · CUSIP: 00972L107

Event date: 2019-03-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
70,221,338
Percent of class
75.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-019394
Form type
SC 13D/A
Filer
AKCEA THERAPEUTICS, INC.
CIK
CIK 1662524
Filed
Apr 02, 2019
Reporting period
Mar 29, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub